Skip to content
Search

Latest Stories

After Robbie Turner, Gail Fleming leaves RPS

Gail Fleming, the director of Education and Professional Development at the Royal Pharmaceutical Society, has decided to resign. Thursday, April 7 will be her last day at the RPS.

In a statement, chief executive Paul Bennett said: “On the 4th March we announced that we were proposing some changes to our executive structure.


“Further to my update on the 24th of March I can announce that Gail Fleming has decided to leave her role as Director of Education and Professional Development and her last day with us will be 07 April 2022."

Bennett wished Fleming luck and thanked "her for her excellent work since joining the organisation in 2018".

He added: “I will be updating everyone on how any changes to our structure enable us to deliver our Royal Charter obligations and our five-year strategy.”

Robbie Turner Robbie Turner

Last week, RPS also announced that "Robbie Turner has decided to leave his role as director of Pharmacy and Membership Experience and his last day with us will be 31 March 2022."

Earlier, on a proposed change to the executive structure, RPS president Claire Anderson commented: “I deeply regret seeing so much speculation in the public domain about a proposed change to the Executive Team when no decision has yet been made, and feel for those involved.

“This is an organisational decision, as it is about operational matters. RPS finances are on a secure footing and this proposal is not about cost savings. We intend to continue our investment in education and professional leadership for the future of the pharmacy profession.

“Our excellent and dedicated teams will continue to advocate on behalf of the profession across all sectors and areas of practice, including education, workforce issues, independent prescribing and inclusion and diversity.

"In particular, our work on education, including post-registration curricula, assessment and credentialing, workforce planning, leadership development and mentoring are strategically important to our profession, right from undergraduate level through foundation to advanced and consultant practice.

"We are completely committed to maintaining this work and should the proposal go ahead, there would still be a leader on the Executive with responsibility for delivering on our education strategy."

In March, RPS said that it had identified two roles at potential risk of redundancy, but did not specify which two roles were going to be axed.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less